blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3003384

EP3003384 - ORAL SOLUTION COMPRISING ATOMOXETINE HYDROCHLORIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.09.2017
Database last updated on 21.08.2024
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Lamda Laboratories S.A.
59, Ioannou Metaxa Str.
Karellas
19400 Koropi
Attiki / GR
[2016/15]
Inventor(s)01 / KARATZAS, Angelos
Markou Botsari 15
GR-15235 Vrilissia Attica / GR
02 / STAPPA, Argyro
Zoodochou Pigis 39A
GR-15231 Chalandri Attica / GR
03 / KOTSIANIS, Ilias
Tralleon 26
GR-14342 Nea Filadelfeia Attica / GR
04 / APOSTOLOU, Konstantinos
Mavromichali 14
GR-15344 Gerakas Attica / GR
 [2016/15]
Representative(s)Roukounas, Dimitrios
Dietlindenstraße 18
80802 München / DE
[2016/15]
Application number, filing date14726544.102.05.2014
[2016/15]
WO2014EP59020
Priority number, dateGR2014010015724.03.2014         Original published format: GR 20140100157
[2016/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015144255
Date:01.10.2015
Language:EN
[2015/39]
Type: A1 Application with search report 
No.:EP3003384
Date:13.04.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 01.10.2015 takes the place of the publication of the European patent application.
[2016/15]
Type: B1 Patent specification 
No.:EP3003384
Date:26.10.2016
Language:EN
[2016/43]
Search report(s)International search report - published on:EP01.10.2015
ClassificationIPC:A61K47/20, A61K47/22, A61K47/00, A61K47/26, A61K31/138, A61K9/00
[2016/19]
CPC:
A61K9/0095 (EP,GR); A61K31/135 (GR); A61K31/138 (EP);
A61K47/20 (EP); A61K47/22 (EP); A61K47/26 (EP)
Former IPC [2016/15]A61K47/26, A61K9/08, A61K31/138
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/15]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ORALE LÖSUNG MIT ATOMOXETIN-HYDROCHLORID[2016/15]
English:ORAL SOLUTION COMPRISING ATOMOXETINE HYDROCHLORIDE[2016/15]
French:SOLUTION ORALE CONTENANT DU CHLORHYDRATE D'ATOMOXÉTINE[2016/15]
Entry into regional phase08.01.2016National basic fee paid 
08.01.2016Designation fee(s) paid 
08.01.2016Examination fee paid 
Examination procedure08.01.2016Examination requested  [2016/15]
20.04.2016Communication of intention to grant the patent
21.06.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.06.2016Fee for grant paid
22.06.2016Fee for publishing/printing paid
19.08.2016Information about intention to grant a patent
19.08.2016Receipt of the translation of the claim(s)
Opposition(s)27.07.2017No opposition filed within time limit [2017/40]
Fees paidRenewal fee
09.03.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.05.2014
AL26.10.2016
CY26.10.2016
DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
MK26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
TR26.10.2016
BG26.01.2017
IS26.02.2017
LU02.05.2017
MT02.05.2017
[2020/34]
Former [2020/15]HU02.05.2014
CY26.10.2016
DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
MK26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
TR26.10.2016
BG26.01.2017
IS26.02.2017
LU02.05.2017
MT02.05.2017
Former [2019/52]HU02.05.2014
CY26.10.2016
DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
MK26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU02.05.2017
MT02.05.2017
Former [2019/48]HU02.05.2014
CY26.10.2016
DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU02.05.2017
MT02.05.2017
Former [2019/31]HU02.05.2014
DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU02.05.2017
MT02.05.2017
Former [2018/43]DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU02.05.2017
MT02.05.2017
Former [2018/17]DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU02.05.2017
Former [2018/06]DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
MC26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU31.05.2017
Former [2017/52]DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
RS26.10.2016
SI26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU31.05.2017
Former [2017/42]DK26.10.2016
EE26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
RS26.10.2016
SM26.10.2016
BG26.01.2017
IS26.02.2017
LU31.05.2017
Former [2017/33]DK26.10.2016
HR26.10.2016
LT26.10.2016
LV26.10.2016
RS26.10.2016
IS26.02.2017
Former [2017/26]HR26.10.2016
LT26.10.2016
LV26.10.2016
RS26.10.2016
IS26.02.2017
Former [2017/12]LV26.10.2016
Cited inInternational search[A]US2005152974  (BOEHM GARTH [US], et al) [A] 1-10 * paragraphs [0244] - [0254] *;
 [A]WO2006020348  (TEVA PHARM FINE CHEMICALS SRL [IT], et al) [A] 1-10 * page 12, lines 7-26 *;
 [A]US2011076239  (REICHELT KATHARINA [DE], et al) [A] 1-10* the whole document *
by applicantEP0052492
    - HUDA. . G ET AL., "Taste masked chewable dispersible tablet of atomoxetine HCI", INTERNATIONAL JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, (2013), vol. 5, no. 1
    - Y. DEEPTHI PRIYA ET AL., "An approach for taste masking of bitter drug atomoxetine HCI", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACEUTICAL RESEARCH, (201104), vol. 2, pages 4,119 - 121
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.